ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "recruitment"

  • Abstract Number: 1180 • ACR Convergence 2021

    Better Websites, Better Match: Assessing Quality of Rheumatology Fellowship Websites

    Hiral Patel1, D. Benjamin Riffe1 and Rachel Wolfe2, 1Wake Forest School of Medicine, Winston Salem, NC, 2Wake Forest Baptist Health, Winston-Salem, NC

    Background/Purpose: The internet has become an indispensable tool for residency and fellowship recruitment. Prospective applicants rely on publicly available information to learn about the application…
  • Abstract Number: 2411 • 2019 ACR/ARP Annual Meeting

    Casting a Wide Net: Comparing Strategies for Recruiting 18-35-year-olds with Rheumatic Disease as Study Participants

    Arif Jetha1, Lori Tucker 2, Julie Bowring 3, Catherine L. Backman 4, Laurie Proulx 5, Vicki Kristman 6 and Monique A.M. Gignac 3, 1Institute for Work & Health, Toronto, ON, Canada, 2British Columbia Children’s Hospital, Vancouver, Canada, 3Institute for Work & Health, Toronto, Canada, 4University of British Columbia, Vancouver, Canada, 5Canadian Arthritis Patient Alliance, Ottawa, Canada, 6Lakehead University, Thunder Bay, Canada

    Background/Purpose: Young adulthood is a unique life phase that spans 18-35 years, and is characterized by healthcare, educational, vocational and social transitions. Experiences in young…
  • Abstract Number: 732 • 2017 ACR/ARHP Annual Meeting

    Progression of Skin Fibrosis Is Associated with Decline in Lung Function in Patients with Diffuse Cutaneous Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis

    Wanlong Wu1, Suzana Jordan2, Nicole Graf3, Janethe Pena4, John Curram5, Yannick Allanore6, Marco Matucci-Cerinic7, Janet E. Pope8, Christopher Denton9, Dinesh Khanna10 and Oliver Distler1, 1Department of Rheumatology, Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland, 3Graf Biostatistics, Winterthur, Switzerland, 4Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ, 5Bayer Plc, Newbury, United Kingdom, 6Department of Rheumatology, Cochin Hospital, Paris Descartes University, Paris, France, 7Dept of Medicine/Div of Rheum, University of Florence, Florence, Italy, 8Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, 9Department of Rheumatology, University College London, Royal Free Hospital, London, United Kingdom, 10Division of Rheumatology, Department of Internal Medicine, Scleroderma Program, University of Michigan, Ann Arbor, MI

    Background/Purpose: Previously, we have identified short disease duration (≤15 months) and low baseline modified Rodnan skin score (mRSS) (≤22/51) as independent predictors of progressive skin…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology